The purpose of the present invention is to provide various kinds of disintegrating tablets having various purposes and applications, such as for pharmaceuticals Chinese medicine and various kinds of foods and comprising various kinds of active ingredients such as the medicinal or nutritional ingredient, the supplement and the food component at a high concentration; and a composition for the disintegrating tablets.

The present invention relates to a composition for a disintegrating tablet, comprising a disintegrator component consisting of only micro-fibrillated cellulose, and an active ingredient; and a disintegrating tablet for pharmaceuticals or foods, comprising the composition.

The present invention provides a process for preparing a pharmaceutical preparation which is to be used for treatment of the viral infections, specifically the infections caused by related RNA virus such as Coronavirus (COVID-19) disease. The present invention also provides the method of treating viral infections or the infections caused by related RNA viruses such as COVID-19 disease using Hordeum or Barley or Barley extracts or the pharmaceutical preparation comprising them and the combinations thereof. The present process is simple, economical, bio friendly, and industrially applicable.

The present invention provides a process for preparing a pharmaceutical preparation which is to be used for treatment of the viral infections, specifically the infections caused by related RNA virus such as Coronavirus (COVID-19) disease. The present invention also provides the method of treating viral infections or the infections caused by related RNA viruses such as COVID-19 disease using Hordeum or Barley or Barley extracts or the pharmaceutical preparation comprising them and the combinations thereof. The present process is simple, economical, bio friendly, and industrially applicable.

A Chinese herbal oral paste includes the following raw material components: dangshen (Codonopsis pilosula), prepared white atractylodes rhizome, prepared black atractylodes rhizome, turmeric, unprocessed germinated barley, villous amomum fruit, coix seed, Alisma plantago-aquatica Linn., peach seed, tall gastrodia tuber, fuling, dried tangerine peel, seaweed, bitter apricot seed, cardamon fruit, perilla fruit, oriental waterplantain rhizome, ricepaperplant pith, Chinese waxgourd peel, kudzu vine root, unprocessed hawthorn fruit, milkvetch root, rice beans, lotus leaf, fortune eupatorium herb leaf, unprocessed cattail pollen, unprocessed rhubarb root and rhizome, inner membrane of chicken gizzard, white mustard seed, agastache rugosa, radish seed, xylitol, donkey-hide gelatin, and tortoise-plastron gelatin.

A Chinese herbal oral paste includes the following raw material components: dangshen (Codonopsis pilosula), prepared white atractylodes rhizome, prepared black atractylodes rhizome, turmeric, unprocessed germinated barley, villous amomum fruit, coix seed, Alisma plantago-aquatica Linn., peach seed, tall gastrodia tuber, fuling, dried tangerine peel, seaweed, bitter apricot seed, cardamon fruit, perilla fruit, oriental waterplantain rhizome, ricepaperplant pith, Chinese waxgourd peel, kudzu vine root, unprocessed hawthorn fruit, milkvetch root, rice beans, lotus leaf, fortune eupatorium herb leaf, unprocessed cattail pollen, unprocessed rhubarb root and rhizome, inner membrane of chicken gizzard, white mustard seed, agastache rugosa, radish seed, xylitol, donkey-hide gelatin, and tortoise-plastron gelatin.

A Chinese herbal oral paste includes the following raw material components: dangshen (Codonopsis pilosula), prepared white atractylodes rhizome, prepared black atractylodes rhizome, turmeric, unprocessed germinated barley, villous amomum fruit, coix seed, Alisma plantago-aquatica Linn., peach seed, tall gastrodia tuber, fuling, dried tangerine peel, seaweed, bitter apricot seed, cardamon fruit, perilla fruit, oriental waterplantain rhizome, ricepaperplant pith, Chinese waxgourd peel, kudzu vine root, unprocessed hawthorn fruit, milkvetch root, rice beans, lotus leaf, fortune eupatorium herb leaf, unprocessed cattail pollen, unprocessed rhubarb root and rhizome, inner membrane of chicken gizzard, white mustard seed, agastache rugosa, radish seed, xylitol, donkey-hide gelatin, and tortoise-plastron gelatin.

Provided are a series of traditional Chinese medicine healthcare preparations for fat elimination and weight reduction, which are traditional Chinese medicine healthcare preparations produced by adding an appropriate raw medicine to basic active pharmaceutical ingredients consisting of rose flower, soybean protein isolate, konjac flour, soybean oligosaccharide, oat, Chinese date, and L-carnitine, or consisting of gardenia, soybean oligosaccharide, L-carnitine, and konjac flour.

Provided are a series of traditional Chinese medicine healthcare preparations for fat elimination and weight reduction, which are traditional Chinese medicine healthcare preparations produced by adding an appropriate raw medicine to basic active pharmaceutical ingredients consisting of rose flower, soybean protein isolate, konjac flour, soybean oligosaccharide, oat, Chinese date, and L-carnitine, or consisting of gardenia, soybean oligosaccharide, L-carnitine, and konjac flour.

The invention provides compositions, methods, and diagnostics for the treatment of metabolic syndromes. In an additional aspect of the invention, compositions and methods of treatment are calibrated to mimic the ileal brake response resulting from surgical intervention, e.g. RYGB, to control metabolic syndrome manifestations and thereby reverse or ameliorate the cardiovascular damage (atherosclerosis, hypertension, lipid accumulation, and the like) resulting from progression of metabolic syndrome. Combination medicaments that act synergistically on the ileal brake and the manifestations of metabolic syndrome are also disclosed.

The invention provides compositions, methods, and diagnostics for the treatment of metabolic syndromes. In an additional aspect of the invention, compositions and methods of treatment are calibrated to mimic the ileal brake response resulting from surgical intervention, e.g. RYGB, to control metabolic syndrome manifestations and thereby reverse or ameliorate the cardiovascular damage (atherosclerosis, hypertension, lipid accumulation, and the like) resulting from progression of metabolic syndrome. Combination medicaments that act synergistically on the ileal brake and the manifestations of metabolic syndrome are also disclosed.